Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: celecoxib

« Back to Dashboard
Celecoxib is the generic ingredient in two branded drugs marketed by Gd Searle, Alembic Pharms Ltd, Apotex Inc, Cipla Ltd, Lupin Ltd, Mylan Pharms Inc, Teva, Torrent Pharms Ltd, and Watson Labs Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for celecoxib. Twenty-six suppliers are listed for this compound.

Summary for Generic Name: celecoxib

Tradenames:2
Patents:0
Applicants:9
NDAs:9
Drug Master File Entries: see list22
Suppliers / Packaging: see list211
Therapeutic Class:Analgesics
Anti-inflammatory Agents

Pharmacology for Ingredient: celecoxib

Clinical Trials for: celecoxib

Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
Status: Active, not recruiting Condition: Healthy

The Impact of Genotype on Plasma and Cerebral Spinal Fluid Pharmacokinetics of Celecoxib in Children
Status: Not yet recruiting Condition: Pharmacokinetics of Celecoxib in Children

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
CELECOXIB
celecoxib
CAPSULE;ORAL078857-004Feb 11, 2015RXNo<disabled><disabled>
Cipla Ltd
CELECOXIB
celecoxib
CAPSULE;ORAL207446-003Sep 23, 2015RXNo<disabled><disabled>
Alembic Pharms Ltd
CELECOXIB
celecoxib
CAPSULE;ORAL204519-001Aug 21, 2015RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: celecoxib

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-004Dec 15, 20065,466,823*PED<disabled>
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-001Dec 31, 1998RE44048*PED<disabled>
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002RE44048*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc